Stock Updates

How has Zimmer Biomet Holdings, Inc.:(NYSE:ZBH) performed recently?

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a large market cap stock with a market cap of 25918.42. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 112.31, a forward P/E of 14.19 and EPS of 1.11. At a stock price of 124.89 (1.20%) it has a dividend yield of 0.77%.

EPS growth for the last five years have been -23.60%, more recently this last year it has grown by -81.50%. The next year growth is going to be about 10.44% and more long-term 11.05% after five years. EPS growth quarter over quarter is *TBA. Sales growth for the past five years have been 7.30% and sales growth quarter over quarter is -16.00%.

For performance, Zimmer Biomet Holdings, Inc. the past week has seen a gain of -3.93%. For the last month performance for Zimmer Biomet Holdings, Inc. is -2.66%. While the last quarter is 7.23% and half year, 21.08%. Finally for the year, performance is 25.07%.

The 52-week high for Zimmer Biomet Holdings, Inc., is at -6.23%, and for the 52-week low it comes to a value of 42.10%. The 20-day simple moving average is -2.11% and 11.36% for the 200-day simple moving average.

Volatility for the week is at 2.22%, and for the month it is 1.48%. Zimmer Biomet Holdings, Inc., has a target price of 140.75.

In terms of debt, long term debt/equity is 1.1, and for total debt/equity Zimmer Biomet Holdings, Inc. has 1.16. The gross margin is 67.20%, while operating margin is 10.30%, the profit margin is 3.00%. The current ratio is 2.4 and the quick ratio is 1.5.

Insider ownership is at 0.20%, with instituitional ownership at 90.40%. Zimmer Biomet Holdings, Inc. has a payout ratio of 82.00%. With the total shares outstanding coming to 207.53. The shares float is 199.57, with the float short at 2.37%, with short ratio coming to 3.22.

In terms of returns, the return on assets see Zimmer Biomet Holdings, Inc., get 0.90%, with its returns on investment at 2.10%. Return on equity is 2.30%. So will the investors see the target price of 140.75, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment